CREON 1212
Generic Name: pancrelipase
Pill imprint CREON 1212 has been identified as Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease.
Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Creon 60,000 units amylase / 12,000 units lipase / 38,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Creon Images
- Generic Name:
- pancrelipase
- Imprint:
-
CREON 1212
- Strength:
- 60,000 units amylase / 12,000 units lipase / 38,000 units protease
- Color:
- Brown / Clear
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Solvay Pharmaceuticals Inc.


